Rogans Care

Rogans Medical Research

Institutional and Clinical Research Profile

ROGANS S.A.S. is a healthcare provider institution (IPS) founded in 2021, with a clinical and operating model designed to strategically support clinical research

A Clinical Ecosystem for Collaborative Research

1.

Five licensed offices

Operating across multiple sites

2.

Specialties with high potential for recruitment and longitudinal follow-up

General medicine, dermatology, psychiatry, internal medicine and clinical nutrition.

3.

In-person, home and virtual care

Our own clinical infrastructure, with home medical care and virtual tools including tele-guidance, teleconsultation and telemedicine.

A hybrid care model that makes recruitment easier

4.

Network of strategic partners

Leading institutions in other medical specialties that significantly expand the diversity and size of the populations available for clinical studies, especially in low- and medium-complexity research.

Rogans Clinical Ecosystem

Regulatory Compliance and Ethical Framework

High bioethical and regulatory standards

High bioethical and regulatory standards

  • Policies, procedures and internal controls for the proper handling of personal and sensitive health data, in strict compliance with Colombia's Law 1581 of 2012
  • Clinical and administrative processes under current licensing in accordance with Resolution 3100 of 2019
Patient-centered care

Patient-centered care

Clinical Traceability

Clinical Traceability

Strategic Enablers for Clinical Research

Research team

ROGANS has a solid, interdisciplinary research team with experience in clinical research, regulation, ethics and regulatory compliance:

Research Ethics Committee - Riesgo de Fracturas S.A.

Research Ethics Committee

ROGANS coordinates its research processes with an external, independent Research Ethics Committee, Riesgo de Fracturas S.A., which is pluralistic and interdisciplinary. This committee reviews research protocols and issues ethical opinions on them, protecting the rights, safety and well-being of participants in line with the national and international ethical principles that apply to research involving human subjects.
This team allows ROGANS to bring together its clinical, scientific, ethical and regulatory capabilities in a comprehensive way.

Our value proposition

We act as a third-party partner that complements the capabilities of the research site, without replacing its clinical, scientific or regulatory role.
Our value proposition is built on our ability to combine:

Population access

Technology

Specialized team

Regulatory compliance

Sponsor engagement

We contribute directly to the feasibility and success of clinical studies.